section name header

Indications ⬇

REMS


VistogardVistogardXuriden

Contraind./Precautions ⬆ ⬇

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects ⬆ ⬇

Vistogard

Interactions ⬆ ⬇

Drug-drug:

Availability ⬆ ⬇

Route/Dosage ⬆ ⬇

Vistogard

Xuriden

US Brand Names ⬆ ⬇

Vistogard, Xuriden

Action ⬆ ⬇

Vistogard
  • Converted into uridine which competitively inhibits cell damage and cell death caused by fluorouracil.
Xuriden
  • Provides uridine to patients who cannot synthesize adequate quantities of uridine due to a genetic defect in uridine nucleotide synthesis.
Therapeutic effects: Vistogard
  • Improved survival in patients experiencing fluorouracil- or capecitabine-induced toxicities.
  • Improvements in hematologic abnormalities and reduction in urinary orotic acid concentrations.

Classifications ⬆ ⬇

Therapeutic Classification: antidotes

Pharmacologic Classification: pyrimidine analogs

Pharmacokinetics ⬆ ⬇

Absorption: Well absorbed following oral administration.

Distribution: Crosses the blood-brain barrier.

Metabolism/Excretion: Undergoes catabolic metabolism in tissues; primarily excreted in urine.

Half-Life: 2–2.5 hr.

Time/Action Profile ⬆ ⬇

(blood levels)

ROUTEONSETPEAKDURATION
POunknown2–3 hrunknown



Patient/Family Teaching ⬆ ⬇

Pronunciation ⬆

URE-i-deen trye-AS-e-tate